NCAM protein and SARS-COV-2 surface proteins: In-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré syndrome

Nervous system involvement after infection with COVID-19 and other coronaviruses

(2020) Yeshun Wu et al.   BRAIN BEHAVIOR AND IMMUNITY

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

(2020) Hua Zhao et al.   LANCET NEUROLOGY

Guillain–Barré Syndrome Associated with SARS-CoV-2

(2020) Gianpaolo Toscano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

(2020) Ling Mao et al.   JAMA Neurology

Human leukocyte antigen‐ DQB1 polymorphisms and haplotype patterns in Guillain‐Barré syndrome

(2019) Shoma Hayat et al.   Annals of Clinical and Translational Neurology

Plasma levels of soluble NCAM in multiple sclerosis

(2018) Nicole Ziliotto et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

UniProt: a worldwide hub of protein knowledge

(2018)   NUCLEIC ACIDS RESEARCH

Neurological Complications during Treatment of Middle East Respiratory Syndrome

(2017) Jee-Eun Kim et al.   Journal of Clinical Neurology

Guillain–Barré Syndrome After Zika Virus Infection in Brazil

(2016) Mateus Santana do Rosário et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond

(2016) Guglielmo Lucchese et al.   AUTOIMMUNITY REVIEWS

Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain–Barré syndrome

(2016) L. Schirmer et al.   JOURNAL OF NEUROLOGY

Virus Variation Resource – improved response to emergent viral outbreaks

(2016) Eneida L. Hatcher et al.   NUCLEIC ACIDS RESEARCH

Paranodal and other autoantibodies in chronic inflammatory neuropathies

(2015) Luis Querol et al.   CURRENT OPINION IN NEUROLOGY

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis

(2015) Stefan Blum et al.   JOURNAL OF NEUROIMMUNOLOGY

Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders

(2015) Panos Stathopoulos et al.   Nature Reviews Neurology

GalaxyPepDock: a protein–peptide docking tool based on interaction similarity and energy optimization

(2015) Hasup Lee et al.   NUCLEIC ACIDS RESEARCH

Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barre syndrome

(2014) S. Sawai et al.   NEUROLOGY

Nodal proteins are target antigens in Guillain-Barré syndrome

(2012) Jérôme J. Devaux et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Guillain–Barré Syndrome

(2012) Nobuhiro Yuki et al.   NEW ENGLAND JOURNAL OF MEDICINE

LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery

(2011) Roman A. Laskowski et al.   Journal of Chemical Information and Modeling

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

(2011) James J. Sejvar et al.   NEUROEPIDEMIOLOGY

Increased Risk of Guillain‐Barré Syndrome following Recent Herpes Zoster: A Population‐Based Study across Taiwan

(2010) Jiunn‐Horng Kang et al.   CLINICAL INFECTIOUS DISEASES

Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome

(2008) Julia Wanschitz* et al.   JOURNAL OF NEUROLOGY